NewAmsterdam Pharma
NAMS
NAMS
130 hedge funds and large institutions have $2.11B invested in NewAmsterdam Pharma in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
8% less capital invested
Capital invested by funds: $2.28B → $2.11B (-$171M)
72% less call options, than puts
Call options by funds: $1.18M | Put options by funds: $4.16M
Holders
130
Holding in Top 10
7
Calls
$1.18M
Puts
$4.16M
Top Buyers
| 1 | +$28.8M | |
| 2 | +$19.2M | |
| 3 | +$18.3M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$17.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$13M | |
| 3 | -$11.8M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$9.87M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.55M |
